Find Unlimited Emails.For Free.
Discover prospects, find their business emails, and build your pipeline with Unifers.
Start for FreeThomas Spiegel
Executive Director, Us Oncology Market Access @Bristol Myers Squibb
Signup · Get unlimited contacts
WORK HISTORY
Executive Director, Us Oncology Market Access @Bristol Myers Squibb
Leading market access strategy for a $10 Billion Oncology franchise, shaping new product development, executing multiple product launches and delivering market access for thousand of patients in need of advanced and innovative oncology treatments
EDUCATION
Lehigh University
bachelor of Science in (B.Sc.) Finance
Rutgers Business School
Master of Business Administration - MBA
Lehigh University
Bachelor of Science
SKILLS
ABOUT THOMAS SPIEGEL
About Strategic and results-driven pharmaceutical executive with over 25 years of experience at Bristol Myers Squibb, specializing in Oncology Market Access, Commercial Strategy, and Global Brand Marketing. Proven track record of leading high-impact product launches, shaping payer strategies, and driving cross-functional initiatives across U.S. and international markets. Passionate about improving patient access and advancing innovative therapies in immuno-oncology. Core Expertise • Oncology Market Access Strategy • Immuno-Oncology Product Launches • Payer & Policy Engagement • Global Commercialization • Value & Pricing Strategy • Cross-Functional Leadership • Sales Force Development • Advanced Payment Models (OCM, EOM, CMMI, Commercial) Career Highlights Executive Director, Oncology US Market Access – Led strategy for expanded oncology portfolio including launch of Opdivo Qvantig and new tumor indications. Influenced clinical development and filing strategies to optimize patient access. Senior Director, Immuno-Oncology Franchise – Directed market access for OPDUALAG, OPDIVO, and YERVOY across multiple tumor types. Spearheaded pricing and access plans for pipeline assets and chaired steering team for OCM 2.0. Global Oncology Commercialization Lead – Oversaw launches and commercialization planning for Yervoy and Nivolumab across diverse international markets. Sales Leadership – ELIQUIS – Elevated district performance from bottom quartile to top third nationally. Piloted innovative access solutions and led regional training initiatives. Education • Executive Education, Marketing – Columbia University • MBA, Finance – Rutgers University • BS, Finance – Lehigh University
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.